Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer: early-phase trial registry
279 of 621 indexed Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #6 of 28,963 conditions by registered trial count.
621 US clinical trials · 279 currently recruiting · #6 of 28,963 conditions by registered trial count
Cancer: 621 US clinical trials tracked, 279 recruiting.
Cancer is the subject of 621 registered US clinical trials on ClinicalTrials.gov, 279 of them currently open to new participants. 31 are in Phase 3-4 (later-stage) and 164 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 31 of these trials.
Open enrollment, early-phase tilt
Cancer has 621 registered US clinical trials, 279 of them open to new participants right now, about 45% of the total.
- 279
- recruiting participants now
- 45%
- of trials open to enrollment
- 31
- in Phase 3-4 (later-stage)
- 31
- top sponsor: M.D. Anderson Cancer Center
Corpus placement: #6 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Cancer on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer is recruiting above its size-band peers.
279 of 621 indexed trials (44.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 31 of 621 trials (5%). 270 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer enrolment sits around 108 participants.
Median target enrolment is 108 among the 616 trials that report a genuine target (sentinel values excluded). 287 of those (46.6%) plan for fewer than 100 participants.
-
Cancer research is mostly interventional.
462 interventional and 159 observational studies make up this index (74.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
621 total, page 6 of 13
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT06858449
Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT06610396
Trial of DFP-14927 in Advanced Solid Tumors
Delta-Fly Pharma
NCT03943004
A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer
M.D. Anderson Cancer Center
NCT06434402
Evaluating the Communication Between Patients and Providers in Cancer Clinics
University of Wisconsin, Madison
NCT06985953
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
Dartmouth-Hitchcock Medical Center
NCT05302375
A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
University of Arizona
NCT06644560
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
University of Maryland, Baltimore
NCT06248216
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Aadi Bioscience
NCT05997017
Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study
University of Miami
NCT06952790
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)
M.D. Anderson Cancer Center
NCT07298096
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
Stanford University
NCT07220343
Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study
Medstar Health Research Institute
NCT07228377
Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment
Mayo Clinic
NCT07221409
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
M.D. Anderson Cancer Center
NCT06801041
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
Yale University
NCT07019259
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
M.D. Anderson Cancer Center
NCT05694650
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
Sunstone Medical
NCT05584826
A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
Massachusetts General Hospital
NCT06172907
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
Icahn School of Medicine at Mount Sinai
NCT04615988
The Gut Microbiome and Immunotherapy Response in Solid Cancers
The University of Texas Medical Branch, Galveston
NCT06050733
Daily Hand-Held Vibration Therapy
Indiana University
NCT04207437
Digital Art Therapy for Young Cancer Survivors
UNC Lineberger Comprehensive Cancer Center
NCT06789666
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NCT07023887
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Children's Hospital of Philadelphia
NCT06458036
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
NCT05783323
FAMILY Sleep Program
University of Miami
NCT06571305
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
M.D. Anderson Cancer Center
NCT06807593
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
University of Pittsburgh
NCT04452305
NIH-AARP Diet and Health Secondary Research Study Based on OH95CN025 Data
National Cancer Institute (NCI)
NCT04750915
Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial
National Cancer Institute (NCI)
NCT00339495
PATHFINDER 2: a Multi-Cancer Early Detection Study
GRAIL
NCT05155605
Gulf Long-Term Follow-Up Study
National Institute of Environmental Health Sciences (NIEHS)
NCT01287000
Vitamin D and Omega-3 Trial (VITAL)
Brigham and Women's Hospital
NCT01169259
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
Anne Murray
NCT07224347
REFLECTION: A Clinical Practice Learning Program for Galleri®
GRAIL
NCT05205967
The Biorepository for Scripps Health
Scripps Translational Science Institute
NCT01006239
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
National Cancer Institute (NCI)
NCT00001163
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling
Memorial Sloan Kettering Cancer Center
NCT03208374
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial
Sunnybrook Health Sciences Centre
NCT02261415
Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center
NCT00587886
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
Hoffmann-La Roche
NCT03768063
Patient-Reported Outcome Version of the Common Criteria for Adverse Events
St. Jude Children's Research Hospital
NCT04050072
Enhancing Cancer Care Of Rural Dwellers
Debra Friedman
NCT04758338
Patient Navigation 2.0
Northwestern University
NCT04234646
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
M.D. Anderson Cancer Center
NCT05436327
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
Abramson Cancer Center at Penn Medicine
NCT04774445
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Invitae Corporation
NCT05219734
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Hoffmann-La Roche
NCT03148418
Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
Memorial Sloan Kettering Cancer Center
NCT01579552
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 116 |
| Phase 2 | 48 |
| Phase 3 | 27 |
| Phase 4 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Cancer right now
279 recruiting of 621 indexed (45% open).
Phase mix: 31 late (III/IV) vs 164 early (I/II) (early-phase heavy).
Top sponsor: M.D. Anderson Cancer Center (31 trials), 9 others listed. 50 shown below, recruiting first. #6 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Cancer?
PlainTrial tracks 621 US clinical trials for Cancer, of which 279 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Cancer?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.